Stock calls, verified track record & performance
0 followers11 calls tracked since May 2026
Track record still in verification
2 of 10 resolved calls needed for an overall hit rate · 9 active
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
Long-Term (1y) — 8 calls, none resolved against exchange prices yet.
Long-Term (1 Year) calls
AI7+·0−-3.2% P&L+24.3% upside left
₹1,207.1
CMP
Entry*
₹1,247.5
Target
₹1,500
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.6h ago
AI8+·0−+1.4% P&L+6.3% upside left
₹766.85
CMP
Entry*
₹756.15
Target
₹815
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.2w ago
BUYELECONElecon Engineering CompanyHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI3+·1−-5.0% P&L+33.0% upside left
₹413.5
CMP
Entry*
₹435.05
Target
₹550
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.3w ago
BUYVIYASHViyash ScientificHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI4+·0−-7.2% P&L+25.6% upside left
₹246.9
CMP
Entry*
₹266
Target
₹310
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.3w ago
BUYKPILKalpataru Projects…Horizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI12+·0−-1.3% P&L+15.9% upside left
₹1,380.2
CMP
Entry*
₹1,398.1
Target
₹1,600
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.4w ago
BUYMEDANTAGlobal HealthHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI12+·2−-0.9% P&L+9.3% upside left
₹1,418.1
CMP
Entry*
₹1,430.9
Target
₹1,550
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.6w ago
BUYJUBLINGREAJubilant IngreviaHorizon: 1 Year* (horizon not stated by the source; assumed from the target's distance) · 11 mo left
AI9+·1−-14.4% P&L+55.4% upside left
₹630.5
CMP
Entry*
₹736.45
Target
₹980
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.7w ago
AI8+·0−-1.5% P&L+24.8% upside left
₹328.55
CMP
Entry*
₹333.65
Target
₹410
NSNarendra Solanki, Anand Rathi· via CNBC Awaaz.8w ago
Showing 1–8 of 8

